Editorial · 30 May 2021
Research articlePublished 5 Dec 2019
Antitubercular drug discovery: the molecular modification as promise tool.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tuberculosis is a chronic infectious disease caused by etiologic agent Mycobacterium tuberculosis. “It has been reported that rates of incidence is increasing and each year around 8.9-9.9 million new cases are detected”. The current TB therapy presents several problems such as long-term therapy, drug resistance, no-compliance to therapy and few therapeutic sources to treat the disease. The discovery of new drugs safer and more efficient is urgent. The molecular modification is an important tool that allows discovering new compounds that can be win these challenges. In this work, we summarize the main strategies useful to obtain a new anti-tubercular drug.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Pharmacy and Pharmacology.
Editorial · 28 May 2021
Nuclear Medicine : A New Aspect In Medicine
Editorial · 24 May 2021
The journal of pharmacy and pharmacology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Pharmacy and Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Luiz Antonio Dutra”
- BylineArticles whose byline prints “Thais Regina Ferreira de Melo”
- BylineArticles whose byline prints “Chung Man Chin”
- BylineArticles whose byline prints “Jean Leandro dos Santos”
